Latest Neuraminidase inhibitors Stories

2010-02-26 09:15:23

A new study shows that a novel antiviral compound is effective against the highly pathogenic H5N1 avian influenza virus, including oseltamivir (Tamiflu)-resistant strains.

2010-02-18 06:00:00

BIRMINGHAM, Ala., Feb. 18 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc.

2010-02-16 14:41:44

An increased dosage of Tamiflu (oseltamivir) for patients with critical illness is unlikely to be required in the treatment of pandemic (H1N1) influenza, contrary to current international guidelines, found a new study in CMAJ (Canadian Medical Association Journal).

2010-02-02 06:08:00

LOURES, Portugal, February 2 /PRNewswire/ -- Hovione is announcing the filing of a new drug application in Japan by its licensee Daiichi Sankyo Company Ltd.

2010-02-01 18:10:32

A targeted program of preventive antiviral medication, combined with the use of hand sanitizers and surface decontamination, was associated with containing the spread of the H1N1 virus in a summer camp setting, according to a report posted online today that will appear in the April print issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

2010-02-01 09:50:00

TAMPA, Fla., Feb. 1 /PRNewswire/ -- Romark Laboratories announced that it has initiated enrollment of patients in a clinical trial of Alinia® (nitazoxanide) for treating acute uncomplicated influenza including illness caused by the currently circulating H1N1 strain.

2010-01-26 08:24:00

BIRMINGHAM, Ala., Jan. 26 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that its partner, Shionogi & Co., Ltd. will launch RAPIACTA, intravenous (i.v.) peramivir anti-viral, to treat patients with influenza in Japan, on January 27, 2010.

2010-01-14 11:43:26

Scientists have developed an alternative method for producing the active ingredient in Tamiflu®, the mainstay for fighting H1N1 and other forms of influenza.

2010-01-13 06:00:00

BIRMINGHAM, Ala., Jan. 13 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that its partner, Shionogi & Co., Ltd. has received marketing and manufacturing approval for intravenous (i.v.) peramivir to treat patients with influenza in Japan.

Word of the Day
  • Sleep; the state or condition of being asleep.
  • The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.
The word 'obdormition' comes from a Latin word meaning "to fall asleep".